Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy

作者：Alexandre Bazinet, Sanam Loghavi, Yue Wei, Álex Bataller, Koji Sasaki, Naszrin Arani, Faezeh Darbaniyan, Kelly S. Chien, Danielle Hammond, Ian Bouligny, Rashmi Kanagal‐Shamanna, Natthakan Thongon, Guilin Tang, Samuel Urrutia, Tapan M. Kadia, Courtney D. DiNardo, Naval Daver, Nicholas J. Short, Ghayas C. Issa, Naveen Pemmaraju, Elias Jabbour, Sa A. Wang, Wei Wang, Gautam Borthakur, Carlos E. Bueso‐Ramos, Farhad Ravandi, L. Jeffrey Medeiros, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Guillermo Montalban‐Bravo · 发表于：Leukemia · 年份：2025 · DOI：10.1038/s41375-025-02711-6 · 被引用次数：4 · 研究领域：Acute Myeloid Leukemia Research、Myeloproliferative Neoplasms: Diagnosis and Treatment、Chronic Myeloid Leukemia Treatments